12-hydroxyeicosatetrenoate (12-HETE) Attenuates AMPA Receptor-mediated Neurotoxicity: Evidence for a G-protein-coupled HETE Receptor
Overview
Authors
Affiliations
12-hydroxyeicosatetraenoic acid (12-HETE) is a neuromodulator that is synthesized during ischemia. Its neuronal effects include attenuation of calcium influx and glutamate release as well as inhibition of AMPA receptor (AMPA-R) activation. Because 12-HETE reduces ischemic injury in the heart, we examined whether it can also reduce neuronal excitotoxicity. When treated with 12-(S)HETE, cortical neuron cultures subjected to AMPA-R-mediated glutamate toxicity suffered up to 40% less damage than untreated cultures. The protective effect of 12-(S)HETE was concentration-dependent (EC50 = 88 nm) and stereostructurally selective. Maximal protection was conferred by 300 nm 12-(S)HETE; 300 nm 15-(S)HETE was similarly protective, but 300 nm 5-(S)HETE was less effective. The chiral isomer 12-(R)HETE offered no protection; neither did arachidonic acid or 12-(S)hydroperoxyeicosatetraenoic acid. Excitotoxicity was calcium-dependent, and 12-(S)HETE was demonstrated to protect by inactivating N and L (but not P) calcium channels via a pertussis toxin-sensitive mechanism. Calcium imaging demonstrated that 12-(S)HETE also attenuates glutamate-induced calcium influx into neurons via a pertussis toxin-sensitive mechanism, suggesting that it acts via a G-protein-coupled receptor. In addition, 12-(S)HETE stimulates GTPgammaS binding (indicating G-protein activation) and inhibits adenylate cyclase in forskolin-stimulated cultures over the same concentration range as it exerts its anti-excitotoxic and calcium-influx attenuating effects. These studies demonstrate that 12-(S)HETE can protect neurons from excitotoxicity by activating a G(i/o)-protein-coupled receptor, which limits calcium influx through voltage-gated channels.
Chataigner M, Martin M, Lucas C, Pallet V, Laye S, Mehaignerie A Nutrients. 2021; 13(3).
PMID: 33801489 PMC: 7998148. DOI: 10.3390/nu13030824.
Hu T, Zhu Q, Hu Y, Kamal G, Feng Y, Manyande A Molecules. 2020; 25(21).
PMID: 33171987 PMC: 7664212. DOI: 10.3390/molecules25215163.
Kanzler M, Van Dyke A, He Y, Hewett J, Hewett S Epilepsia Open. 2018; 3(2):255-263.
PMID: 29881804 PMC: 5983117. DOI: 10.1002/epi4.12221.
12-HETrE inhibits platelet reactivity and thrombosis in part through the prostacyclin receptor.
Tourdot B, Adili R, Isingizwe Z, Ebrahem M, Freedman J, Holman T Blood Adv. 2018; 1(15):1124-1131.
PMID: 29296755 PMC: 5728320. DOI: 10.1182/bloodadvances.2017006155.
The expansive role of oxylipins on platelet biology.
Yeung J, Hawley M, Holinstat M J Mol Med (Berl). 2017; 95(6):575-588.
PMID: 28528513 PMC: 5547901. DOI: 10.1007/s00109-017-1542-4.